To evaluate whether scNanoGPS can robustly detect major cell types in human tumors, we performed scNanoRNAseq on 4 frozen tumors collected from renal cell carcinoma (RCC1, RCC2) and melanoma (MEL1, MEL2) patients (Supplementary Table 2). The gene discussed is RCC2; the disease is hereditary clear cell renal cell carcinoma.